GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sophia Genetics SA (FRA:90B) » Definitions » Price-to-Free-Cash-Flow

Sophia Genetics (FRA:90B) Price-to-Free-Cash-Flow : N/A (As of Dec. 12, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sophia Genetics Price-to-Free-Cash-Flow?

As of today (2024-12-12), Sophia Genetics's share price is €3.18. Sophia Genetics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.73. Hence, Sophia Genetics's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Sophia Genetics's Price-to-Free-Cash-Flow or its related term are showing as below:

FRA:90B's Price-to-Free-Cash-Flow is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 16.455
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Sophia Genetics's Free Cash Flow per Share for the three months ended in Sep. 2024 was €-0.15. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €-0.73.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -7.00% per year.

During the past 6 years, Sophia Genetics's highest 3-Year average Free Cash Flow per Share Growth Rate was -7.00% per year. The lowest was -20.20% per year. And the median was -13.60% per year.


Sophia Genetics Price-to-Free-Cash-Flow Historical Data

The historical data trend for Sophia Genetics's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sophia Genetics Price-to-Free-Cash-Flow Chart

Sophia Genetics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - -

Sophia Genetics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sophia Genetics's Price-to-Free-Cash-Flow

For the Health Information Services subindustry, Sophia Genetics's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sophia Genetics's Price-to-Free-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sophia Genetics's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Sophia Genetics's Price-to-Free-Cash-Flow falls into.



Sophia Genetics Price-to-Free-Cash-Flow Calculation

Sophia Genetics's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=3.18/-0.728
=N/A

Sophia Genetics's Share Price of today is €3.18.
Sophia Genetics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.73.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Sophia Genetics  (FRA:90B) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Sophia Genetics Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Sophia Genetics's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Sophia Genetics Business Description

Traded in Other Exchanges
Address
La Pièce 12, Rolle, CHE, CH-1180
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Sophia Genetics Headlines

No Headlines